AFT Pharmaceuticals Ltd (OTCPK:AFTPF)
$ 0 0 (0%) Market Cap: 205.17 Mil Enterprise Value: - PE Ratio: 25.89 PB Ratio: 3.63 GF Score: 90/100

Half Year 2021 AFT Pharmaceuticals Ltd Earnings Call Transcript

Nov 18, 2020 / 09:00PM GMT
Operator

Thank you for standing by, and welcome to the AFT Pharmaceuticals Half Year Results Analyst Briefing. (Operator Instructions)

Representing the company today, we have our Managing Director, Dr. Hartley Atkinson, and Malcolm Tubby, our CFO, from AFT Pharmaceuticals. I would now like to hand the conference over to Hartley Atkinson. Please go ahead.

Hartley Atkinson
AFT Pharmaceuticals Limited - Founder, CEO, MD & Executive Director

Thank you, Ashley. Thank you, everyone, for joining us today. So maybe just to go through the presentation, if that's okay. So obviously, we have the first page, which is the title page, Page 2. We have the various disclaimers, so please just be aware of those. They're pretty standard. And maybe then to move on to Page 3, which is the financial highlights for H1 FY 2021. So basically, to look at some top line numbers, The number of countries which we're selling Maxigesic in continues to grow. We're up 21% to 34 countries. That's an important matrix as over time, clearly, as we sell it in more countries, then that will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot